Objective (OCL) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
10 Jun, 2026Executive summary
Revenue for H1 FY25 grew 6% year-over-year to $61.3 million, with annualized recurring revenue (ARR) up 10% to $107.0 million and net profit after tax at $17.0 million.
Adjusted EBITDA increased 6% to $23.3 million, and cash balance rose 26% to $84.3 million, reflecting strong operational performance.
84% of revenue was recurring, the highest ever, driven by the transition to subscription software and SaaS, with SaaS CAGR at 29%.
Interim unfranked dividend of 9.0 cents per share declared, payable 17 March 2025; total dividends paid in the half-year were $16.1 million.
No external borrowings; strong cash position supports ongoing R&D and global expansion.
Financial highlights
Adjusted EBITDA margin exceeded 39%, with gross margin at 94% and operating margin at 32%.
R&D investment reached $15.1 million, representing 30% of software revenue, with 52% capitalised and 44% of all-time R&D investment in the last five years.
Operating cash flow was $12.6 million, down from $16.3 million due to payment cycle seasonality; cash conversion ratio was 54%.
Earnings per share rose to 17.9 cents, and net tangible assets per share increased to 37.9 cents.
No large, one-off deals impacted results; growth was spread across business lines.
Outlook and guidance
Management targets 15% ARR growth for FY2025, with strong early H2 momentum and a robust pipeline.
Focus remains on organic growth, with M&A as a strategic pillar if aligned opportunities arise.
Continued investment in R&D and accelerated delivery models to drive future sales and conversions.
Major acceleration for the 360 product line anticipated in FY26 and beyond.
Expansion of AI capabilities and use cases across the product portfolio.
Latest events from Objective
- Revenue, profit, and ARR posted double-digit growth, supported by SaaS and AI innovation.OCL
H1 202610 Jun 2026 - ARR up 15% to AUD 120.2m, 13% net profit growth, and strong R&D investment drive outlook.OCL
H2 202510 Jun 2026 - Revenue up 6%, ARR up 11%, EBITDA up 66%, all revenue now subscription-based.OCL
H2 202410 Jun 2026 - Strong growth, SaaS transition, and key approvals defined the 2024 AGM.OCL
AGM 202412 Jan 2026 - Strong recurring revenue growth, high R&D investment, and strategic AI-driven expansion highlighted.OCL
AGM 202525 Nov 2025